EBITDA Margin % is calculated as EBITDA divided by its Revenue. Teijin's EBITDA for the
three
months ended in Mar. 2026 was 円-2,243 Mil. Teijin's Revenue for the
three
months ended in Mar. 2026 was 円213,312 Mil. Therefore, Teijin's EBITDA margin for the quarter that ended in Mar. 2026 was -1.05%.
Teijin (TSE:3401) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Teijin EBITDA Margin % Related Terms
Teijin EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Teijin's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Teijin's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teijin EBITDA Margin % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Teijin's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Teijin's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teijin (TSE:3401) has a EBITDA Margin % of -1.05% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Teijin and its competitors. According to the industry distribution chart, Teijin ranks #472 out of 549 companies in the Conglomerates industry, placing it in the top 86%.
Is Teijin's EBITDA Margin % too high?
Teijin's current EBITDA Margin % is -1.05%. Based on the distribution chart, Teijin ranks #472 out of 549 companies in the Conglomerates industry, which is in the bottom quartile relative to peers. Overall, Teijin has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Teijin's EBITDA Margin % compare to HON and MMM?
According to the Conglomerates industry distribution chart, Teijin ranks #472 out of 549 companies for EBITDA Margin %. This places Teijin in the lower half of its industry. The industry median EBITDA Margin % is 12.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Conglomerates company?
The median EBITDA Margin % among Conglomerates companies is 12.24, based on 549 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Teijin and its competitors. For the Conglomerates industry, the median EBITDA Margin % is 12.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teijin's current EBITDA Margin % is -1.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teijin stock overvalued right now?
Based on GuruFocus' analysis, Teijin (TSE:3401) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,205.18, compared to a current price of 円1,639.50 — trading 36% above its estimated fair value. The current EBITDA Margin % is -1.05%. Teijin's overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Teijin (TSE:3401), the current EBITDA Margin % is -1.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Teijin (TSE:3401) Overvalued in 2026?
Based on GuruFocus' analysis, Teijin stock appears to be overvalued.
The current stock price of 円1,639.50 is trading 36% above its estimated GF Value™ of 円1,205.18.
GuruFocus considers Teijin to be Significantly Overvalued.
Key valuation signals for TSE:3401:
EBITDA Margin %: -1.05%
GF Value™: 円1,205.18 vs. price of 円1,639.50 (36% above fair value)
No single metric tells the full story. See the TSE:3401 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Teijin Ltd is a Japanese industrial conglomerate engaged in healthcare, materials, textiles, and other businesses. The company organizes itself into four primary segments. The Healthcare segment manufactures and sells pharmaceuticals, medical devices, and home medical services. The Material segment covers aramid fibers, polycarbonate resins, carbon fibers, and composite molding materials. The Textiles/Products segment produces polyester fibers and textile products. The Others segment includes businesses outside the reporting segments, such as battery components, membranes, regenerative medicine, and implantable medical devices.
62GF Score
Get the complete analysis for TSE:3401
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3401 has been successfully added to your 
